Table 3. Univariate logistic regression with infection as the outcome.
Characteristic | N | OR | 95% CI | P-value |
Gender | 364 | |||
Female | — | — | ||
Male | 0.63 | 0.40, 1.02 | 0.059 | |
Age | 364 | 1.01 | 1.00, 1.03 | 0.14 |
Weight | 364 | 0.99 | 0.98, 1.01 | 0.4 |
Height | 364 | 0.05 | 0.00, 0.63 | 0.021 |
Body mass index | 363 | 1.01 | 0.97, 1.05 | 0.6 |
Smoking | 364 | |||
No | — | — | ||
Yes | 0.79 | 0.45, 1.35 | 0.4 | |
Type 2 diabetes | 364 | |||
No | — | — | ||
Yes | 2.23 | 1.36, 3.74 | 0.002 | |
COPD | 364 | |||
No | — | — | ||
Yes | 1.03 | 0.14, 5.35 | >0.9 | |
Heart failure | 364 | |||
No | — | — | ||
Yes | 3.81 | 1.96, 7.59 | <0.001 | |
Hypertension | 364 | |||
No | — | — | ||
Yes | 1.83 | 1.14, 2.97 | 0.013 | |
Dyslipidemia | 364 | |||
No | — | — | ||
Yes | 1.05 | 0.67, 1.64 | 0.8 | |
Operation | 364 | |||
CABG | — | — | ||
CABG + VR | 1.01 | 0.42, 2.33 | >0.9 | |
Other | 0.34 | 0.08, 1.04 | 0.09 | |
VR | 0.89 | 0.51, 1.52 | 0.7 | |
Duration of surgery | 363 | 1 | 1.00, 1.00 | 0.4 |
Preop hemoglobin | 363 | 0.86 | 0.76, 0.95 | 0.006 |
Antibiotic | 364 | |||
2 gm cefazolin | — | — | ||
2 gm cefazolin + gentamicin | 0.81 | 0.28, 2.06 | 0.7 | |
Postop hemoglobin | 364 | 0.91 | 0.78, 1.04 | 0.2 |
Hemoglobin at discharge | 364 | 0.96 | 0.83, 1.12 | 0.6 |
Preop creatinine | 364 | 1 | 1.00, 1.00 | 0.7 |
Postop creatinine | 364 | 1 | 1.00, 1.00 | 0.3 |
HbA1c | 364 | 1.24 | 1.12, 1.39 | <0.001 |
Transfusion | 364 | |||
No | — | — | ||
Yes | 1.64 | 0.84, 3.39 | 0.2 | |
PRBC transfusion | 363 | |||
No | — | — | ||
Yes | 1.58 | 0.83, 3.18 | 0.2 | |
PRBC transfusion amount | 364 | 1.09 | 1.01, 1.19 | 0.028 |
Platelet transfusion | 364 | |||
No | — | — | ||
Yes | 0.99 | 0.58, 1.67 | >0.9 | |
Preop INR | 364 | 0.96 | 0.25, 3.35 | >0.9 |
Postop INR | 364 | 0.97 | 0.36, 2.32 | >0.9 |
Preop PT | 364 | 1.01 | 0.90, 1.11 | 0.9 |
Postop PT | 364 | 1 | 0.91, 1.07 | >0.9 |
Preop aPTT | 364 | 1.02 | 1.00, 1.04 | 0.036 |
Postop aPTT | 364 | 1.01 | 0.99, 1.02 | 0.4 |
LOS | 364 | 1.07 | 1.04, 1.11 | <0.001 |